RIPE-KG · Version 1.1.0 · Resource

ripekg:registry-evidence/RIPEA323E9769EC8E8E48

https://w3id.org/ripe/ripe-kg/registry-evidence/RIPEA323E9769EC8E8E48
SubjectPredicateObject
ripekg:evaluation/RIPEA323E9769EC8E8E48 prov:used ripekg:registry-evidence/RIPEA323E9769EC8E8E48
ripekg:registry-evidence/RIPEA323E9769EC8E8E48 rdf:type rdfs:Resource
ripekg:registry-evidence/RIPEA323E9769EC8E8E48 rdf:type owl:Thing
ripekg:registry-evidence/RIPEA323E9769EC8E8E48 rdf:type ripe:IntegrityAssessmentEvidenceIntegrity assessment evidence
ripekg:registry-evidence/RIPEA323E9769EC8E8E48 rdf:type ripe:RegistryEvidenceRegistry evidence
ripekg:registry-evidence/RIPEA323E9769EC8E8E48 rdf:type tido:Evidence
ripekg:registry-evidence/RIPEA323E9769EC8E8E48 prov:wasGeneratedBy ripekg:evidence-aggregation/RIPEA323E9769EC8E8E48
ripekg:registry-evidence/RIPEA323E9769EC8E8E48 prov:wasMemberOf ripekg:research-integrity-assessment/RIPEA323E9769EC8E8E48
ripekg:registry-evidence/RIPEA323E9769EC8E8E48 ripe:concerns ripekg:work/10.1007%2Fs11745-017-4295-5Flaxseed Oil Supplementation Improve Gene Expression Levels of PPAR‐γ, LP(a), IL‐1 and TNF‐α in Type 2 Diabetic Patients with Coronary Heart Disease
ripekg:registry-evidence/RIPEA323E9769EC8E8E48 ripe:registrationAssessmentRationale Registry registration date (study_first_submit_qc_date) is missing or empty.
ripekg:registry-evidence/RIPEA323E9769EC8E8E48 tido:supports ripekg:integrity-assessment-hypothesis/RIPEA323E9769EC8E8E48-human-2-2
ripekg:registry-evidence/RIPEA323E9769EC8E8E48 tido:supports ripekg:integrity-assessment-hypothesis/RIPEA323E9769EC8E8E48-inspectai-2-2